Puma Biotechnology, Inc.

PBYI
As of the close on Sep 25, 2026
Price
$9.77
Market cap
—
The latest share count on file is too old
P/E (diluted TTM)
—
The fourth quarter's per-share figure could not be confirmed from the annual report
EPS (TTM)
—
The fourth quarter's per-share figure could not be confirmed from the annual report
Dividend yield
—
Dividend records do not yet cover the latest payments

Figures shown here come from public SEC filings. Dates beside each section show the available history.

How Puma Biotechnology, Inc. Makes Money

Follow each dollar of revenue through to what shareholders keep.

From revenue to net income

Pick a year or quarter. Each band's width is its dollar amount.

Source: Puma Biotechnology, Inc. — 10-K filed Mar 2, 2023

Financial Summary

Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.

Loading financial history…

SEC filings supply these figures; updates after the dates shown are not included. This page includes 15 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 15, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.

Ownership

Who holds the shares, as reported in SEC ownership filings.

Reported 13F positions

Each row shows what a filer reported for one date, not a current position. The link opens that filing.

Filer Report date Shares Value Filing
Universal- Beteiligungs- und Servicegesellschaft mbH 2026-03-31 39,308 $251K SEC filing
Vise Technologies, Inc. 2026-03-31 40,298 $240K SEC filing
PRELUDE CAPITAL MANAGEMENT, LLC 2026-03-31 18,448 $118K SEC filing
MANUFACTURERS LIFE INSURANCE COMPANY, THE 2026-03-31 11,765 $75.2K SEC filing
Sterling Capital Management LLC 2026-03-31 1,425 $9.11K SEC filing
OSAIC HOLDINGS, INC. 2026-03-31 11,669 $74.6K SEC filing
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 2026-03-31 2,330 $14.9K SEC filing
Police & Firemen's Retirement System of New Jersey 2026-03-31 15,719 $100K SEC filing
Allspring Global Investments Holdings, LLC 2026-03-31 17,066 $109K SEC filing
Farther Finance Advisors, LLC 2026-03-31 566 $3.83K SEC filing
NISA INVESTMENT ADVISORS, LLC 2026-03-31 342 $2.19K SEC filing
AMERICAN CENTURY COMPANIES INC 2026-03-31 1,916,346 $12.2M SEC filing
Nuveen, LLC 2026-03-31 79,101 $505K SEC filing
Wealth Preservation Advisors, LLC 2026-03-31 1 $6 SEC filing
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC 2026-03-31 1,710 $10.9K SEC filing
FIRST TRUST ADVISORS LP 2026-03-31 123,513 $789K SEC filing
GOLDMAN SACHS GROUP INC 2026-03-31 669,719 $4.28M SEC filing
True Wealth Design, LLC 2026-03-31 123 $786 SEC filing
LSV ASSET MANAGEMENT 2026-03-31 1,182,868 Not shown SEC filing
Sunbelt Securities, Inc. 2026-03-31 30 $192 SEC filing
  • Each value is checked against Puma Biotechnology, Inc.'s share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
  • Value not shown for 1 row: the filed value is about 1,000 times too small for the share count at Puma Biotechnology, Inc.'s share price.

120 filers have only one report here.

Unusually large insider trades

Each trade is compared with the other insider trades of the same kind in the same security among Puma Biotechnology, Inc.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.

  • 2021-06-11 · Senderowicz Adrian: Larger than all 25 other insider sales of COMMON STOCK on file. SEC filing
  • 2021-06-10 · WILSON TROY EDWARD: Larger than 24 of the 25 other insider sales of COMMON STOCK on file. SEC filing
  • 2021-06-10 · Miller Ann Calby: Larger than 23 of the 25 other insider sales of COMMON STOCK on file. SEC filing

Purchases & sales (open market or private)

SecurityCodePriceFiling
2026-06-12Senderowicz Adrian · DirectorCommon StockS — Open market or private sale−27,0007.20SEC filing
2026-06-12MOYES JAY M · DirectorCommon StockS — Open market or private sale−22,0007.22SEC filing
2026-06-12WILSON TROY EDWARD · DirectorCommon StockS — Open market or private sale−10,8007.20SEC filing
2026-06-12Stuglik Brian M · DirectorCommon StockS — Open market or private sale−8,1007.20SEC filing
2026-06-12Dorval Allison · DirectorCommon StockS — Open market or private sale−11,6107.20SEC filing
2026-01-07HUNT DOUGLAS M · See RemarksCommon StockS — Open market or private sale−5,0145.88SEC filing
2026-01-07NOUGUES MAXIMO F · Chief Financial OfficerCommon StockS — Open market or private sale−6,4055.88SEC filing
2026-01-07AUERBACH ALAN H · President and CEOCommon StockS — Open market or private sale−18,0125.88SEC filing

Showing 8 of 10 rows

Grants, exercises, tax & gifts

SecurityCodeFiling
2026-06-11Stuglik Brian M · DirectorCommon StockA — Grant, award, or other acquisition+27,000SEC filing
2026-06-11MOYES JAY M · DirectorCommon StockA — Grant, award, or other acquisition+27,000SEC filing
2026-06-11Cesano Alessandra · DirectorCommon StockA — Grant, award, or other acquisition+27,000SEC filing
2026-06-11Dorval Allison · DirectorCommon StockA — Grant, award, or other acquisition+27,000SEC filing
2026-06-11WILSON TROY EDWARD · DirectorCommon StockA — Grant, award, or other acquisition+27,000SEC filing
2026-06-11Senderowicz Adrian · DirectorCommon StockA — Grant, award, or other acquisition+27,000SEC filing
2026-06-11MILLER MICHAEL PATRICK · DirectorCommon StockA — Grant, award, or other acquisition+27,000SEC filing
2026-02-18NOUGUES MAXIMO F · Chief Financial OfficerCommon StockA — Grant, award, or other acquisition+46,739SEC filing

Showing 8 of 10 rows

These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.